U.S. Food and Drug Administration | MIDD Training Module 3 – Impact and Decision-Making @US_FDA | Uploaded 2 months ago | Updated 1 hour ago
Clinical Pharmacologist Dr. Colin Pillai discusses if there are differences between an industry versus a regulatory setting, or if there are differences between the approach regulatory scientists or decision makers would take versus an industry scientist or decision maker? He covers the topic of why perspectives matter and how models inform decisions.
This module is part of the educational series “Model-Informed Drug Development (MIDD): Methods Advancing Medical Products to Patients”. The educational content was developed for regulatory scientists by experts in the field in partnership with the Critical Path Institute and funded by FDA CDER Office of Translational Sciences. As part of Multidisciplinary Education and Exchange initiatives, CDER’s Quantitative Medicine Center of Excellence is making this resource accessible to all, supporting community-wide educational enrichment.
Disclaimer: The presentations in this educational series reflect the views of the presenters and should not be construed to represent FDA’s views or policies.
Clinical Pharmacologist Dr. Colin Pillai discusses if there are differences between an industry versus a regulatory setting, or if there are differences between the approach regulatory scientists or decision makers would take versus an industry scientist or decision maker? He covers the topic of why perspectives matter and how models inform decisions.
This module is part of the educational series “Model-Informed Drug Development (MIDD): Methods Advancing Medical Products to Patients”. The educational content was developed for regulatory scientists by experts in the field in partnership with the Critical Path Institute and funded by FDA CDER Office of Translational Sciences. As part of Multidisciplinary Education and Exchange initiatives, CDER’s Quantitative Medicine Center of Excellence is making this resource accessible to all, supporting community-wide educational enrichment.
Disclaimer: The presentations in this educational series reflect the views of the presenters and should not be construed to represent FDA’s views or policies.